Table 2.
Weighted prevalencea of virological suppression and HIVDR among ADR12 participants
| Survey outcome | n/N | Percentage prevalence (95% CI) |
|---|---|---|
| VL suppression | ||
| all | 493/533 | 95.0 (93.4–96.5) |
| male | 169/182 | 97.7 (91.3–99.4)b |
| female | 324/351 | 93.6 (91.9–95.2) |
| agec <34 years | 267/287 | 94.8 (91.1–98.5) |
| age ≥34 years | 225/245 | 95.1 (91.3–98.9) |
| HIVDR | ||
| any | 28/533 | 4.7 (3.3–6.1) |
| NRTI | 23/533 | 4.4 (3.1–5.8) |
| NNRTI | 26/533 | 4.6 (3.3–6.0) |
| NRTI+NNRTI | 22/533 | 4.4 (3.0–5.8) |
| PI | 1/533 | 0.1 (0.01–0.2) |
| HIVDR among VFs | ||
| any | 28/30 | 96.1 (72.9–99.6)b |
| NRTI | 23/30 | 90.3 (65.6–97.9)b |
| NNRTI | 26/30 | 94.1 (74.3–98.9)b |
| NRTI+NNRTI | 22/30 | 89.5 (64.7–97.5)b |
| PI | 1/30 | 1.1 (0.14–3.6) |
a
All prevalences are weighted and accounted for the two-stage clustered survey design.
b
Log-transformed CI.
c
One missing age.